Andre Lacroix, MD

CHUM Universit de Montral
Endocrine Division

Biographical Sketch:
Dr Andre Lacroix is Professor of Medicine at the Centre hospitalier de l’Université de Montréal (CHUM), where he has served as Chairman of the Department of Medicine and Associate Director General for Medical and Academic Affairs. He is a past president of the Canadian Society of Endocrinology and Metabolism (CSEM) and is currently member of the executive board of the International Society of Endocrinology. He is co-editor of the Adrenal Section of UpToDate (Boston, MA) and on the Editorial board of several endocrinology journals. He received the Robert Volpé 2010 award from CSEM in recognition for his contributions to Endocrinology in Canada. He is a Fellow of the Canadian Academy of Health Sciences. His major areas of interest include the pathophysiology of adrenal tumors and hyperplasias leading to Cushing’s syndrome and primary aldosteronism. His group pioneered the identification of the role of aberrant adrenal expression of hormone receptors leading to adrenal overgrowth and overfunction. Other interests include new drugs in the therapy of Cushing’s disease and primary aldosteronism, of adrenocortical cancer and pheochromocytomas.
ACTH Independent Macronodular Adrenal Hyperplasia: Diagnosis and Management
Ectopic ACTH Cushing's syndrome caused by a large-cell neuroendocrine lung carcinoma responding to desmopressin
Improvements in the Clinical Signs and Symptoms of Cushing's Disease Following 12 Months' Treatment with Pasireotide are Not Restricted to Patients Who Achieve UFC Control
Pasireotide Monotherapy in Cushing's Disease: a single-centre experience with 5-year extension of Phase III trial
Cushing's Syndrome Exacerbation During Pregnancy: Stimulation of Cortisol-secreting Adenoma by Placental ACTH
Silent Somatotroph Adenomas
FP29 Adrenal Tumors & Pheochromocytoma
M27 ACTH Independent Macronodular Adrenal Hyperplasia: Diagnosis and Management
OR29 Adrenal Tumors & Pheochromocytoma